FDA Issues Warning Over Misuse of Ketamine Therapy

FDA Issues Warning Over Misuse of Ketamine Therapy

The New York Times - Business:

Unsupervised treatment — fueled by telemedicine prescriptions — for various psychiatric problems poses a number of health risks, the agency said.

This post first appeared in The New York Times - Business. Read the original article.